文献速递临床生化临床免疫

巨肌钙蛋白T的识别:病例报告与不可重现的肌钙蛋白T结果

Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results.
PubMed 文献 · Clin Chem Lab Med · 2021-09-09

本文报告四例巨肌钙蛋白T病例,表现为9分钟与18分钟变体检测高敏肌钙蛋白T(hs-cTnT)结果持续偏低(比值<0.80)。三例因使用受不可重现结果影响的Roche hs-cTnT批号而偶然发现,需双份检测。通过免疫球蛋白去除、EDTA及重组cTnT混合研究确认巨肌钙蛋白T,其中一例同时存在cTnI和cTnT巨复合物,但多次商业检测显示cTn真实升降,符合急性心肌损伤。

要点

  • 9分钟与18分钟变体hs-cTnT比值<0.80提示巨肌钙蛋白T可能。
  • 巨肌钙蛋白T可导致hs-cTnT结果不可重现,需双份检测。
  • 免疫球蛋白去除和混合研究可辅助识别巨肌钙蛋白T。

核心结论

  • 识别了多例巨肌钙蛋白T并描述了相关临床和生化特征。

研究设计与样本

  • 病例报告系列,描述四例巨肌钙蛋白T病例,采用免疫球蛋白去除(Protein A和PEG沉淀)、EDTA及重组cTnT混合研究进行鉴定。

主要发现

  • 四例巨肌钙蛋白T中,9分钟变体hs-cTnT结果低于18分钟变体,比值<0.80。
  • 三例因使用受不可重现结果影响的Roche hs-cTnT批号而偶然发现,需双份检测。
  • 与重组cTnT或EDTA混合研究显示回收率与对照不同。
  • 一例患者cTnI和cTnT均存在高分子量复合物,多次商业检测显示cTn升降符合真实急性心肌损伤。

临床怎么用

  • 当hs-cTnT结果不可重现或与临床不符时,可比较9分钟与18分钟变体比值(<0.80)提示巨肌钙蛋白T。
  • 怀疑巨肌钙蛋白T时,可进行免疫球蛋白去除或EDTA/重组cTnT混合研究辅助确认。
  • 对受影响样本应双份检测以避免误判。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Macrotroponin is due to cardiac troponin (cTn) binding to endogenous cTn autoantibodies. While previous studies showed a high incidence of macrotroponin affecting cTnI assays, reports of macrotroponin T, particularly without cTnI reactivity, have been rare. Although the clinical significance of macrotroponin is not fully understood, macroenzymes and complexes are recognised to cause confusion in interpretation of laboratory results. The potential for adverse clinical consequences due to misinterpretation of affected results is very high. METHODS: We describe four cases of macrotroponin T with persistently low high sensitivity cTnT (hs-cTnT) by the 9 min compared to the 18 min variant of the assay. Three cases were serendipitously identified due to the use of a lot number of Roche hs-cTnT affected by non-reproducible results, necessitating measurement of cTnT in duplicate. We identified and characterised these macrotroponin specimens by immunoglobulin depletion (Protein A and PEG precipitation), mixing studies with EDTA and recombinant cTnT. RESULTS: In cases of macro-cTnT, a lower result occurred on the hs-cTnT using the 9 min compared to 18 min variant assay (ratio of 9-18 min hs-cTnT <0.80). Mixing studies with recombinant cTnT or EDTA demonstrated a difference in recovery vs. controls. One of these patients demonstrated a high molecular weight complex for cTnI and cTnT demonstrating a macrocomplex involving both cTn. This patient demonstrated a rise and fall in cTn when measured by several commercial assays consistent with genuine acute cardiac injury. CONCLUSIONS: We identified several cases of macro-cTnT and described associated clinical and biochemical features.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lam L, Ha L, Heron C, et al. Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results. Clin Chem Lab Med. 2021. PMID: 34496163. doi:10.1515/cclm-2021-0626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。